Ozanimod Wins FDA Approval in Ulcerative Colitis

(MedPage Today) -- Ozanimod (Zeposia) was approved by the FDA to treat ulcerative colitis in adults, Bristol Myers Squibb said on Thursday.
The once-daily oral medication is the first sphingosine 1-phosphate (S1P) receptor modulator approved for...